Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra

OBJECTIVES: To investigate real-world short-term outcomes among patients with systemic JIA starting tocilizumab or anakinra. METHODS: This analysis included all systemic JIA patients within the UK Biologics for Children with Rheumatic Diseases study starting tocilizumab or anakinra between 2010 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearsley-Fleet, Lianne, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293481/
https://www.ncbi.nlm.nih.gov/pubmed/30137641
http://dx.doi.org/10.1093/rheumatology/key262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293481/
https://www.ncbi.nlm.nih.gov/pubmed/30137641
http://dx.doi.org/10.1093/rheumatology/key262

Ejemplares similares